Baidu
map

Circulation:非心脏术后心肌损伤预测30天死亡率

2013-05-17 高晓方 译 医学论坛网

  荷兰一项研究表明,术后心肌损伤为非心脏手术后30天死亡率的独立预测因子;肌钙蛋白监测有助于改善非心脏手术患者预后。论文于5月10日在线发表于《循环》(Circulation)。   此项观察性单中心队列研究共纳入2232例中、高危非心脏手术患者(年龄≥60岁)。在术后三天内测定肌钙蛋白。评估术后心肌损伤(肌钙蛋白I水平>0.06 mcg/L)与30天全因死亡率的相关性。  

  荷兰一项研究表明,术后心肌损伤为非心脏手术后30天死亡率的独立预测因子;肌钙蛋白监测有助于改善非心脏手术患者预后。论文于5月10日在线发表于《循环》(Circulation)。

  此项观察性单中心队列研究共纳入2232例中、高危非心脏手术患者(年龄≥60岁)。在术后三天内测定肌钙蛋白。评估术后心肌损伤(肌钙蛋白I水平>0.06 mcg/L)与30天全因死亡率的相关性。

  结果显示,共有315例(19%)患者出现心肌损伤。56例(3%)患者发生全因死亡。肌钙蛋白轻度升高(0.07~0.59 mcg/L)的相对危险度为2.4,肌钙蛋白升高10至100倍(≥0.60mcg/L)的相对危险度为4.2。依据通用定义,10例(0.6%)患者被诊断为心肌梗死,其中1例为ST段抬高型心肌梗死。


Myocardial Injury after Noncardiac Surgery and its Association with Short-Term Mortality.
BACKGROUND
To identify patients at risk for postoperative myocardial injury and death, it has been suggested to measure cardiac troponin routinely after noncardiac surgery. Such monitoring was implemented in our hospital. The aim of this study was to determine the predictive value of postoperative myocardial injury, as measured by troponin elevation, on 30 day mortality after noncardiac surgery.
METHODS AND RESULTS
This observational single center cohort study included 2,232 consecutive intermediate to high risk noncardiac surgery patients aged 60 and above operated in 2011. Troponin was measured on the first three postoperative days. Log binomial regression analysis was used to estimate the association between postoperative myocardial injury (troponin I level >0.06 mcg/L) and all-cause 30-day mortality. Myocardial injury was found in 315 (19%) patients. All-cause death occurred in 56 (3%) patients. The relative risk of a minor increase in troponin (0.07-0.59 mcg/L) was 2.4 (95% CI 1.3-4.2, p<0.01), and the relative risk of a 10-100 fold increase in troponin (≥0.60mcg/L) was 4.2 (95% CI 2.1-8.6, p<0.01). A myocardial infarction according to the universal definition was diagnosed in 10 patients (0.6%), of which one (0.06%) had ST-elevation myocardial infarction.
CONCLUSIONS
Postoperative myocardial injury is an independent predictor of 30-day mortality after noncardiac surgery. Implementation of postoperative troponin monitoring as standard of care is feasible and might be helpful to improve the prognosis of patients undergoing noncardiac surgery.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1819240, encodeId=c5ba181924032, content=<a href='/topic/show?id=aba89940943' target=_blank style='color:#2F92EE;'>#非心脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99409, encryptionId=aba89940943, topicName=非心脏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Dec 22 16:54:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977749, encodeId=b47f19e77497b, content=<a href='/topic/show?id=93a211600a' target=_blank style='color:#2F92EE;'>#30天#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1160, encryptionId=93a211600a, topicName=30天)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sat Sep 28 09:54:00 CST 2013, time=2013-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310035, encodeId=abfa131003513, content=<a href='/topic/show?id=ddd95126e4e' target=_blank style='color:#2F92EE;'>#心肌损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51267, encryptionId=ddd95126e4e, topicName=心肌损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Sun May 19 01:54:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396762, encodeId=1fdf1396e62fc, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun May 19 01:54:00 CST 2013, time=2013-05-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1819240, encodeId=c5ba181924032, content=<a href='/topic/show?id=aba89940943' target=_blank style='color:#2F92EE;'>#非心脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99409, encryptionId=aba89940943, topicName=非心脏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Dec 22 16:54:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977749, encodeId=b47f19e77497b, content=<a href='/topic/show?id=93a211600a' target=_blank style='color:#2F92EE;'>#30天#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1160, encryptionId=93a211600a, topicName=30天)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sat Sep 28 09:54:00 CST 2013, time=2013-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310035, encodeId=abfa131003513, content=<a href='/topic/show?id=ddd95126e4e' target=_blank style='color:#2F92EE;'>#心肌损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51267, encryptionId=ddd95126e4e, topicName=心肌损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Sun May 19 01:54:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396762, encodeId=1fdf1396e62fc, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun May 19 01:54:00 CST 2013, time=2013-05-19, status=1, ipAttribution=)]
    2013-09-28 smlt2008
  3. [GetPortalCommentsPageByObjectIdResponse(id=1819240, encodeId=c5ba181924032, content=<a href='/topic/show?id=aba89940943' target=_blank style='color:#2F92EE;'>#非心脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99409, encryptionId=aba89940943, topicName=非心脏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Dec 22 16:54:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977749, encodeId=b47f19e77497b, content=<a href='/topic/show?id=93a211600a' target=_blank style='color:#2F92EE;'>#30天#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1160, encryptionId=93a211600a, topicName=30天)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sat Sep 28 09:54:00 CST 2013, time=2013-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310035, encodeId=abfa131003513, content=<a href='/topic/show?id=ddd95126e4e' target=_blank style='color:#2F92EE;'>#心肌损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51267, encryptionId=ddd95126e4e, topicName=心肌损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Sun May 19 01:54:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396762, encodeId=1fdf1396e62fc, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun May 19 01:54:00 CST 2013, time=2013-05-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1819240, encodeId=c5ba181924032, content=<a href='/topic/show?id=aba89940943' target=_blank style='color:#2F92EE;'>#非心脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99409, encryptionId=aba89940943, topicName=非心脏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Dec 22 16:54:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977749, encodeId=b47f19e77497b, content=<a href='/topic/show?id=93a211600a' target=_blank style='color:#2F92EE;'>#30天#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1160, encryptionId=93a211600a, topicName=30天)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sat Sep 28 09:54:00 CST 2013, time=2013-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310035, encodeId=abfa131003513, content=<a href='/topic/show?id=ddd95126e4e' target=_blank style='color:#2F92EE;'>#心肌损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51267, encryptionId=ddd95126e4e, topicName=心肌损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Sun May 19 01:54:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396762, encodeId=1fdf1396e62fc, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun May 19 01:54:00 CST 2013, time=2013-05-19, status=1, ipAttribution=)]

相关资讯

术前高剂量他汀可预防PCI相关炎症和心肌损伤

  2012年世界心脏病学大会于4月18~21日在阿联酋迪拜召开,会上公布了我国北京大学第三医院研究人员开展的一项研究。该研究表明,于经皮冠脉介入(PCI)术前给予48小时的阿托伐他汀80 mg治疗可抑制PCI相关炎症,且对心肌具有一定的保护作用;高剂量与低剂量的阿托伐他汀组在安全性方面没有差异。   研究中,86例行PCI的冠心病(CHD)患者被随机分为对照组(n=30)、低剂

Baidu
map
Baidu
map
Baidu
map